| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |